Jazz Pharmaceuticals plc Fair Value, Assets, Level 1 to Level 2 Transfers, Amount
Jazz Pharmaceuticals plc (JAZZ) had Fair Value, Assets, Level 1 to Level 2 Transfers, Amount of $0 as of 2013-09-30, per its 10-Q filed 2013-11-05.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssetsLevel1ToLevel2TransfersAmount · last filed 2013-11-05
- 2013-09-30: Fair Value, Assets, Level 1 to Level 2 Transfers, Amount $0.00.
- 2013-06-30: Fair Value, Assets, Level 1 to Level 2 Transfers, Amount $0.00.
- 2013-03-31: Fair Value, Assets, Level 1 to Level 2 Transfers, Amount $0.00.
- 2012-12-31: Fair Value, Assets, Level 1 to Level 2 Transfers, Amount $0.00.
| Period end | Fair Value, Assets, Level 1 to Level 2 Transfers, Amount |
|---|---|
| 2013-09-30 | $0.00 10-Q · filed 2013-11-05 |
| 2013-06-30 | $0.00 10-Q · filed 2013-08-06 |
| 2013-03-31 | $0.00 10-Q · filed 2013-05-07 |
| 2012-12-31 | $0.00 10-Q · filed 2013-11-05 |
| 2012-09-30 | $0.00 10-Q · filed 2012-11-09 |
| 2012-06-30 | $0.00 10-Q · filed 2012-08-07 |
| 2012-03-31 | $0.00 10-Q · filed 2012-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |
| Elanco Animal Health Inc (ELAN) | United States | $11.177B | -61.80 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |